Some BPH patients may exhibit elevated serum levels of prostate-specific acid phosphatase (PAP), which is a glycoprotein secreted by the prostate (Hakalahti et al. 1993; Sarwar et al. 2017; Zou et al. 2017). Here, ACP3 is linked to benign prostatic hyperplasia.